(Q46916782)

English

Reduced postprandial proinsulinaemia and 32-33 split proinsulinaemia after a mixed meal in type 2 diabetic patients following sensitization to insulin with pioglitazone

scientific article published on 2 November 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17980009

Reduced postprandial proinsulinaemia and 32-33 split proinsulinaemia after a mixed meal in type 2 diabetic patients following sensitization to insulin with pioglitazone (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17980009

Clifford J Bailey

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17980009

author name string

Michael B Cooper

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17980009

Khulood Al Majali

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17980009

D John Betteridge

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17980009

publication date

2 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17980009

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17980009

68

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17980009

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17980009

738-746

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17980009

The effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Hyperproinsulinemia is associated with increased beta cell demand after hemipancreatectomy in humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Long-term in vitro exposure to high glucose increases proinsulin-like-molecules release by isolated human islets

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Long-term elevation of free fatty acids leads to delayed processing of proinsulin and prohormone convertases 2 and 3 in the pancreatic beta-cell line MIN6.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Fatty acid metabolism and insulin secretion in pancreatic beta cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Proinsulin is an independent predictor of coronary heart disease: Report from a 27-year follow-up study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Concentrations of proinsulin like molecules predict coronary heart disease risk independently of insulin: prospective data from the Caerphilly Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Do increased proinsulin concentrations explain the excess risk of coronary heart disease in diabetic and prediabetic subjects?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Association of proinsulin and insulin resistance with coronary artery disease in non-diabetic south Indian men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Postprandial lipid metabolism and beta-cell function in non-insulin-dependent (type 2) diabetes mellitus after a mixed meal with a high fat content.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

PPAR gamma and human metabolic disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Muscle-specific Pparg deletion causes insulin resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Role of peroxisome proliferator-activated receptor-gamma in the glucose-sensing apparatus of liver and beta-cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Clinical evidence of thiazolidinedione-induced improvement of pancreatic beta-cell function in patients with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Rosiglitazone, but not glyburide, reduces circulating proinsulin and the proinsulin:insulin ratio in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Influence of treatment with acarbose or glibenclamide on insulin sensitivity in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Proinsulin and insulin concentrations in relation to carotid wall thickness: Insulin Resistance Atherosclerosis Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Insulin, intact and split proinsulin, and coronary artery disease in young men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Role of glucagon-like peptide-1 in the pathogenesis and treatment of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Normal proinsulin processing despite beta-cell dysfunction in persistent hyperinsulinaemic hypoglycaemia of infancy (nesidioblastosis).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Kinetics of human connecting peptide in normal and diabetic subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Insulin degradation: progress and potential

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Interaction between specific fatty acids, GLP-1 and insulin secretion in humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03113.X

21 January 2018

Identifiers

10.1111/J.1365-2265.2007.03113.X

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17980009

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17980009

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46916782&oldid=2137692590"